Zenith Drugs Ltd Financials
Company Logo

Zenith Drugs Ltd Financial Statement

Zenith Drugs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Invest in Zenith Drugs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Zenith Drugs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual131.62
Operating Expenses Annual114.70
Operating Profit Annual17.59
Interest Annual3.00
Depreciation1.30
Net Profit Annual9.54
Tax Annual3.76

Zenith Drugs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.20
Cash Flow from Operations-12.49
Cash Flow from Investing25.52
Cash Flow from Financing-4.48
Cash Flow at the End8.74

Zenith Drugs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)14.47
PBIT Margin (%)13.48
PBT Margin (%)8.98
Net PROFIT Margin (%)7.25
Return On Networth / Equity (%)26.44
Return On Networth /Employed (%)27.46
Return On Assets (%)14.79
Total Debt / Equity (X)0.62
Asset Turnover Ratio (%)2.04

Zenith Drugs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual10.94
Total Current Assets Annual112.84
Non Current Assets Annual21.34
Total Shareholders Funds Annual62.22
Total Assets Annual134.17

Zenith Drugs Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Dec 4, 2024, Zenith Drugs Ltd has a market capitalization of 107.52 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Zenith Drugs Ltd is debt-free with a debt-to-equity ratio of 0.38.
In FY 2023 , Zenith Drugs Ltd recorded a total revenue of approximately 131.62 Cr marking a significant milestone in the company's financial performance.
Zenith Drugs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately Infinity% and 0.2% annually, respectively..
Zenith Drugs Ltd's current PE ratio is 11.27.
Zenith Drugs Ltd's ROCE averaged 21.2% from the FY ending March 2022 to 2024, with a median of 20.8%. It peaked at 22.1% in March 2022, reflecting strong capital efficiency over the period..
Zenith Drugs Ltd's latest EBIT is Rs. 16.29 Cr, surpassing the average EBIT of Rs. 10.61 Cr over the 5 years..